Back
ProQR Therapeutics NV Quote, Financials, Valuation and Earnings
Invest. Do Good. Get Rewarded. Just $0.25/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
51
PRQR
ProQR Therapeutics NV
Last Price:
3.62
Seasonality Move:
18.99%
7 Day Trial
ALL ACCESS PASS
$
7
Access The Stock Grader Trading Tool From "The King Of Quants"
More details here...ProQR Therapeutics NV Price Quote
$3.62
+0.01 (+0.28%)
(Updated: November 22, 2024 at 1:10 PM ET)
ProQR Therapeutics NV Key Stats
Buy
51
ProQR Therapeutics NV (PRQR)
is a Buy
Day range:
$3.59 - $3.70
52-week range:
$1.18 - $4.62
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
15.18
P/B ratio:
13.7%
Volume:
235.6K
Avg. volume:
2.8M
1-year change:
154.23%
Market cap:
$382.3M
Revenue:
$7.1M
EPS:
$-0.32
How Much Does ProQR Therapeutics NV Make?
-
How Much Are ProQR Therapeutics NV's Sales Annually?
PRQR Revenues are $7.1M -
How Much Profit Does ProQR Therapeutics NV's Make A Year?
PRQR net income is -$30.4M
Is ProQR Therapeutics NV Growing As A Company?
-
What Is ProQR Therapeutics NV's Growth Rate Quarterly?
Quarterly YoY revenue growth is 1.83% -
What Is ProQR Therapeutics NV's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
ProQR Therapeutics NV Stock Price Performance
-
Did ProQR Therapeutics NV Stock Go Up Last Month?
ProQR Therapeutics NV share price went down by -10.86% last month -
Did PRQR's Share Price Rise Over The Last Year?
PRQR share price rose by 154.23% over the past 1 year
What Is ProQR Therapeutics NV 52-Week High & Low?
-
What Is ProQR Therapeutics NV’s 52-Week High Share Price?
ProQR Therapeutics NV has traded as high as $4.62 over the past 52 weeks -
What Is ProQR Therapeutics NV’s 52-Week Low Share Price?
ProQR Therapeutics NV has traded as low as $1.18 over the past 52 weeks
ProQR Therapeutics NV Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy ProQR Therapeutics NV?
-
How Much Debt Does ProQR Therapeutics NV Have?
Total long term debt quarterly is $5M -
How Much Cash Does ProQR Therapeutics NV Have?
Cash and short term investments quarterly total is $99.9M -
What Is ProQR Therapeutics NV’s Book Value Per Share?
Book value per share is 0.34
Is ProQR Therapeutics NV Cash Flow Positive?
-
What Is PRQR Cash Flow From Operations?
Cash flow from operations (TTM) is -$35.7M -
What Is ProQR Therapeutics NV’s Cash Flow From Financing?
Cash flow from financing (TTM) is -$2.4M -
What Is ProQR Therapeutics NV’s Cash Flow From Investing?
Cash flow from investing (TTM) is $4M
ProQR Therapeutics NV Return On Invested Capital
-
Is Management Doing A Good Job?
PRQR return on invested capital is -59.09% -
What Is ProQR Therapeutics NV Return On Assets?
ROA measures how assets are converting to revenues and is -19.08% -
What Is PRQR Return On Equity?
ROE is a measure of profitability and is -66.59%
ProQR Therapeutics NV Earnings Date & Stock Price
-
What Is ProQR Therapeutics NV's Stock Price Today?
A single share of PRQR can be purchased today for 3.61 -
What Is ProQR Therapeutics NV’s Stock Symbol?
ProQR Therapeutics NV trades on the nasdaq under the ticker symbol: PRQR -
When Is ProQR Therapeutics NV’s Next Earnings Date?
The next quarterly earnings date for ProQR Therapeutics NV is scheduled on March 13, 2025 -
When Is PRQR's next ex-dividend date?
ProQR Therapeutics NV's next ex-dividend date is November 22, 2024 -
How To Buy ProQR Therapeutics NV Stock?
You can buy ProQR Therapeutics NV shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
ProQR Therapeutics NV Competitors
-
Who Are ProQR Therapeutics NV's Competitors?
Below is a list of companies who compete with ProQR Therapeutics NV or are related in some way:
ProQR Therapeutics NV Dividend Yield
-
What Is PRQR Dividend Yield?
ProQR Therapeutics NV’s dividend yield currently is 0% -
What Is ProQR Therapeutics NV’s Payout Ratio?
ProQR Therapeutics NV’s payout ratio is 0% -
When Did ProQR Therapeutics NV Last Pay A Dividend?
The latest dividend pay date is November 22, 2024 -
What Is ProQR Therapeutics NV’s Dividend Per Share?
ProQR Therapeutics NV pays a dividend of $0.00 per share
ProQR Therapeutics NV Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 42.92% |
| Revenue: | 183.35% | -66.32% |
Analyst Recommendations
| Buy Recommendations: | 3 |
|---|---|
| Hold Recommendations: | 1 |
| Sell Recommendations: | 0 |
| Price Target: | 7.03 |
| Upside from Last Price: | 94.74% |